Exercise induces interleukin-8 receptor (CXCR2) expression in human skeletal muscle

Experimental Physiology

Volumn 92, Issue 1, 2007, Pages 233-240

  Frydelund Larsen, Lone ^a   Penkowa, Milena ^b   Akerstrom, Thorbjorn ^a   Zankari, Alaa ^a   Nielsen, Søren ^a   Pedersen, Bente Klarlund ^a,c  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR2; MESSENGER RNA;

ADULT; ARTICLE; ERGOMETER; EXERCISE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; MALE; MUSCLE BIOPSY; NORMAL HUMAN; OXYGEN CONSUMPTION; PROTEIN EXPRESSION; RANDOMIZATION; SKELETAL MUSCLE; VASCULAR ENDOTHELIUM; VASTUS LATERALIS MUSCLE; VOLUNTEER;

EID: 33846261504     PISSN: 09580670     EISSN: 1469445X     Source Type: Journal    
DOI: 10.1113/expphysiol.2006.034769     Document Type: Article

References (55)

1. Addison CL, Daniel TO, Burdick MD, Liu H, Ehlert JE, Xue YY, Buechi L, Walz A, Richmond A & Strieter RM (2000). The CXC chemokine receptor 2, CXCR2, is the putative receptor for ELR+ CXC chemokine-induced angiogenic activity. Immunopharmacology 165, 5269-5277.
2. Akagi K, Ikeda Y, Sumiyoshi Y, Kimura Y, Kinoshita J, Miyazaki M & Abe T (2002). Estimation of angiogenesis with anti-CD105 immunostaining in the process of colorectal cancer development. Surgery 131, S109-S113.
3. Akerstrom TC, Steensberg A, Keller P, Keller C, Penkowa M & Pedersen BK (2005). Exercise induces interleukin-8 expression in human skeletal muscle. J Physiol 563, 507-516.
4. Andersen P & Henriksson J (1977). Capillary supply of the quadriceps femoris muscle of man: adaptive response to exercise. J Physiol 270, 677-690.
5. Baggiolini M, Dewald B & Moser B (1997). Human chemokines: an update. Annu Rev Immunol 15, 675-705.
6. Baggiolini M, Walz A & Kunkel SL (1989). Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J Clin Invest 84, 1045-1049.
7. Bek EL, McMillen MA, Scott P, Angus LD & Shaftan GW (2002). The effect of diabetes on endothelin, interleukin-8 and vascular endothelial growth factor-mediated angiogenesis in rats. Clin Sci (Lond) 103 (Suppl. 48), 424S-429S.
8. Belperio JA, Keane MP, Arenberg DA, Addison CL, Ehlert JE, Burdick MD & Strieter RM (2000). CXC chemokines in angiogenesis. J Leukoc Biol 68, 1-8.
9. Breen EC, Johnson EC, Wagner H, Tseng HM, Sung LA & Wagner PD (1996). Angiogenic growth factor mRNA responses in muscle to a single bout of exercise. J Appl Physiol 81, 355-361.
10. Cerretti DP, Kozlosky CJ, Vanden BT, Nelson N, Gearing DP & Beckmann MP (1993). Molecular characterization of receptors for human interleukin-8, GRO/melanoma growth-stimulatory activity and neutrophil activating peptide-2. Mol Immunol 30, 359-367.
11. Chan MH, Carey AL, Watt MJ & Febbraio MA (2004). Cytokine gene expression in human skeletal muscle during concentric contraction: evidence that IL-8, like IL-6, is influenced by glycogen availability. Am J Physiol Regul Integr Comp Physiol 287, R322-R327.
12. Duff SE, Li C, Garland JM & Kumar S (2003). CD105 is important for angiogenesis: evidence and potential applications. FASEB J 17, 984-992.
13. Febbraio MA & Pedersen BK (2002). Muscle-derived interleukin-6: mechanisms for activation and possible biological roles. FASEB J 16, 1335-1347.
14. Febbraio MA & Pedersen BK (2005). Contraction-induced myokine production and release: is skeletal muscle an endocrine organ? Exerc Sport Sci Rev 33, 114-119.
15. Fonsatti E, Altomonte M, Nicotra MR, Natali PG & Maio M (2003). Endoglin (CD105): a powerful therapeutic target on tumor-associated angiogenetic blood vessels. Oncogene 22, 6557-6563.
16. Forsythe JA, Jiang BH, Iyer NV, Agani F, Leung SW, Koos RD & Semenza GL (1996). Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 16, 4604-4613.
17. Gavin TP, Spector DA, Wagner H, Breen EC & Wagner PD (2000). Nitric oxide synthase inhibition attenuates the skeletal muscle VEGF mRNA response to exercise. J Appl Physiol 88, 1192-1198.
18. Gavin TP & Wagner PD (2001). Effect of short-term exercise training on angiogenic growth factor gene responses in rats. J Appl Physiol 90, 1219-1226.
19. Gavin TP & Wagner PD (2002). Attenuation of the exercise-induced increase in skeletal muscle Flt-1 mRNA by nitric oxide synthase inhibition. Acta Physiol Scand 175, 201-209.
20. Guidi AJ, Fischer L, Harris JR & Schnitt SJ (1994). Microvessel density and distribution in ductal carcinoma in situ of the breast. J Natl Cancer Inst 86, 614-619.
21. Gustafsson T, Puntschart A, Kaijser L, Jansson E & Sundberg CJ (1999). Exercise-induced expression of angiogenesis-related transcription and growth factors in human skeletal muscle. Am J Physiol Heart Circ Physiol 276, H679-H685.
22. Heidemann J, Ogawa H, Dwinell MB, Rafiee P, Maaser C, Gockel HR, Otterson MF, Ota DM, Lugering N, Domschke W & Binion DG (2003). Angiogenic effects of interleukin 8 (CXCL8) in human intestinal microvascular endothelial cells are mediated by CXCR2. J Biol Chem 278, 8508-8515.
23. Holmes WE, Lee J, Kuang WJ, Rice GC & Wood WI (1991). Structure and functional expression of a human interleukin-8 receptor. Science 253, 1278-1280.
24. Hudlicka O, Brown M & Egginton S (1992). Angiogenesis in skeletal and cardiac muscle. Physiol Rev 72, 369-417.
25. Inoue K, Slaton JW, Eve BY, Kim SJ, Perrotte P, Balbay MD, Yano S, Bar-Eli M, Radinsky R, Pettaway CA & Dinney CP (2000). Interleukin 8 expression regulates tumorigenicity and metastases in androgen-independent prostate cancer. Clin Cancer Res 6, 2104-2119.
26. Jensen L, Pilegaard H, Neufer PD & Hellsten Y (2004). Effect of acute exercise and exercise training on VEGF splice variants in human skeletal muscle. Am J Physiol Regul Integr Comp Physiol 287, R397-R402.
27. Ji LL, Gomez-Cabrera MC, Steinhafel N & Vina J (2004). Acute exercise activates nuclear factor (NF)-κB signaling pathway in rat skeletal muscle. FASEB J 18, 1499-1506.
28. Ji LL, Gomez-Cabrera MC & Vina J (2006). Exercise and hormesis: activation of cellular antioxidant signaling pathway. Ann N Y Acad Sci 1067, 425-435.
29. Koch AE, Polverini PJ, Kunkel SL, Harlow LA, Dipietro LA, Elner VM, Elner SG & Strieter RM (1992). Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 258, 1798-1801.
30. Krupinski J, Kaluza J, Kumar P, Kumar S & Wang JM (1994). Role of angiogenesis in patients with cerebral ischemic stroke. Stroke 25, 1794-1798.
31. Lloyd PG, Prior BM, Yang HT & Terjung RL (2003). Angiogenic growth factor expression in rat skeletal muscle in response to exercise training. Am J Physiol Heart Circ Physiol 284, H1668-H1678.
32. Lundby C, Nordsborg N, Kusuhara K, Kristensen KM, Neufer PD & Pilegaard H (2005). Gene expression in human skeletal muscle: alternative normalization method and effect of repeated biopsies. Eur J Appl Physiol 95, 351-360.
33. Mahoney DJ, Carey K, Fu MH, Snow R, Cameron-Smith D, Parise G & Tarnopolsky MA (2004). Real-time RT-PCR analysis of housekeeping genes in human skeletal muscle following acute exercise. Physiol Genomics 18, 226-231.
34. Miettinen M, Lindenmayer AE & Chaubal A (1994). Endothelial cell markers CD31, CD34, and BNH9 antibody to H- and Y-antigens - evaluation of their specificity and sensitivity in the diagnosis of vascular tumors and comparison with von Willebrand factor. Mod Pathol 7, 82-90.
35. Miller DW, Graulich W, Karges B, Stahl S, Ernst M, Ramaswamy A, Sedlacek HH, Muller R & Adamkiewicz J (1999). Elevated expression of endoglin, a component of the TGF-β-receptor complex, correlates with proliferation of tumor endothelial cells. Int J Cancer 81, 568-572.
36. Mizukami Y, Jo WS, Duerr EM, Gala M, Li J, Zhang X, Zimmer MA, Iliopoulos O, Zukerberg LR, Kohgo Y, Lynch MP, Rueda BR & Chung DC (2005). Induction of interleukin-8 preserves the angiogenic response in HIF-1α-deficient colon cancer cells. Nat Med 11, 992-997.
37. Nieman DC, Davis JM, Henson DA, Walberg-Rankin J, Shute M, Dumke CL, Utter AC, Vinci DM, Carson JA, Brown A, Lee WJ, McAnulty SR & McAnulty LS (2003). Carbohydrate ingestion influences skeletal muscle cytokine mRNA and plasma cytokine levels after a 3-h run. J Appl Physiol 94, 1917-1925.
38. Norrby K (1996). Interleukin-8 and de novo mammalian angiogenesis. Cell Prolif 29, 315-323.
39. Olfert IM, Breen EC, Mathieu-Costello O & Wagner PD (2001). Skeletal muscle capillarity and angiogenic mRNA levels after exercise training in normoxia and chronic hypoxia. J Appl Physiol 91, 1176-1184.
40. Pedersen BK, Steensberg A, Fischer C, Keller C, Keller P, Plomgaard P, Febbraio M & Saltin B (2003a). Searching for the exercise factor: is IL-6 a candidate? J Muscle Res Cell Motil 24, 113-119.
41. Pedersen BK, Steensberg A, Keller P, Keller C, Fischer C, Hiscock N, van Hall G, Plomgaard P & Febbraio MA (2003b). Muscle-derived interleukin-6: lipolytic, anti-inflammatory and immune regulatory effects. Pflugers Arch 446, 9-16.
42. Prior BM, Yang HT & Terjung RL (2004). What makes vessels grow with exercise training? J Appl Physiol 97, 1119-1128.
43. Richardson RS, Wagner H, Mudaliar SR, Henry R, Noyszewski EA & Wagner PD (1999). Human VEGF gene expression in skeletal muscle: effect of acute normoxic and hypoxic exercise. Am J Physiol Heart Circ Physiol 277, H2247-H2252.
44. Sanchez-Elsner T, Botella LM, Velasco B, Langa C & Bernabeu C (2002). Endoglin expression is regulated by transcriptional cooperation between the hypoxia and transforming growth factor-β pathways. J Biol Chem 277, 43799-43808.
45. Singh RK, Varney ML, Buyukberber S, Ino K, Ageitos AG, Reed E, Tarantolo S & Talmadge JE (1999). Fas-FasL-mediated CD4+ T-cell apoptosis following stem cell transplantation. Cancer Res 59, 3107-3111.
46. Smith DR, Polverini PJ, Kunkel SL, Orringer MB, Whyte RI, Burdick MD, Wilke CA & Strieter RM (1994). Inhibition of interleukin 8 attenuates angiogenesis in bronchogenic carcinoma. J Exp Med 179, 1409-1415.
47. Smith-McCune KK & Weidner N (1994). Demonstration and characterization of the angiogenic properties of cervical dysplasia. Cancer Res 54, 800-804.
48. Steensberg A, van Hall G, Osada T, Sacchetti M, Saltin B & Klarlund Pedersen B (2000). Production of interleukin-6 in contracting human skeletal muscles can account for the exercise-induced increase in plasma interleukin-6. J Physiol 529, 237-242.
49. Strieter RM, Burdick MD, Gomperts BN, Belperio JA & Keane MP (2005). CXC chemokines in angiogenesis. Cytokine Growth Factor Rev 16, 593-609.
50. Strieter RM, Kunkel SL, Elner VM, Martonyi CL, Koch AE, Polverini PJ & Elner SG (1992). Interleukin-8. A corneal factor that induces neovascularization. Am J Pathol 141, 1279-1284.
51. Strieter RM, Polverini PJ, Kunkel SL, Arenberg DA, Burdick MD, Kasper J et al. (1995). The functional role of the ELR motif in CXC chemokine-mediated angiogenesis. J Biol Chem 270, 27348-27357.
52. Torsney E, Charlton R, Parums D, Collis M & Arthur HM (2002). Inducible expression of human endoglin during inflammation and wound healing in vivo. Inflamm Res 51, 464-470.
53. Wang JM, Deng X, Gong W & Su S (1998). Chemokines and their role in tumor growth and metastasis. J Immunol Meth 220, 1-17.
54. Wang JM, Kumar S, Pye D, Haboubi N & Al-Nakib L (1994). Breast carcinoma: comparative study of tumor vasculature using two endothelial cell markers. J Natl Cancer Inst 86, 386-388.
55. Yang SK, Eckmann L, Panja A & Kagnoff MF (1997). Differential and regulated expression of C-X-C, C-C, and C-chemokines by human colon epithelial cells. Gastroenterology 113, 1214-1223.